Literature DB >> 22723319

Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility.

Michelle R Jones1, Gregorio Chazenbalk, Ning Xu, Angela K Chua, Tamar Eigler, Emebet Mengesha, Yen-Hao Chen, Jung-Min Lee, Marita Pall, Xiaohui Li, Yii-Der I Chen, Kent D Taylor, Ruchi Mathur, Ronald M Krauss, Jerome I Rotter, Richard S Legro, Ricardo Azziz, Mark O Goodarzi.   

Abstract

CONTEXT: Polycystic ovary syndrome (PCOS) is a heterogeneous common genetic disorder characterized by hyperandrogenemia and insulin resistance. Alterations in gene expression profiles of the ovary and adipose tissue identified the candidate gene FBJ murine osteosarcoma viral oncogene homolog (FOS) for further investigation of expression changes in metabolic tissues and genetic studies.
OBJECTIVE: The objective of the study was to confirm the underexpression of the FOS gene in sc adipose and determine whether variants in this gene are risk factors for PCOS.
DESIGN: RT-PCR was performed in sc fat from women with and without PCOS. Genotyping of single-nucleotide polymorphisms in the FOS locus was performed to test for association with PCOS.
SETTING: The study was conducted at a tertiary care academic institution. PARTICIPANTS: Twenty-two PCOS and 13 control subjects were recruited for gene expression studies. We assembled a discovery genotyping cohort of 354 cases and 161 controls and a replication cohort of 476 cases and 315 controls, all of whom were Caucasian. MAIN MEASUREMENTS: Gene expression by quantitative real-time RT-PCR, FOS genotype, and PCOS status were measured.
RESULTS: FOS expression was confirmed to be reduced in PCOS adipose tissue. Three single-nucleotide polymorphisms were significantly associated with PCOS in the discovery cohort (rs8006998, P = 0.0031; rs8013918, P = 0.0006; rs8013942, P = 0.0087). rs8006998 was also associated with PCOS in the replication cohort (P = 0.013).
CONCLUSIONS: Differential gene expression in sc fat and genetic association at the FOS locus in PCOS subjects implicates a role for this transcription factor in PCOS. FOS dysfunction may be a common factor between hyperandrogenism and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22723319      PMCID: PMC3431575          DOI: 10.1210/jc.2011-2153

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

1.  Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4.

Authors:  Y Zhao; J E Nichols; R Valdez; C R Mendelson; E R Simpson
Journal:  Mol Endocrinol       Date:  1996-11

2.  Expression and enzymatic activity of the P450c17 gene in human adipose tissue.

Authors:  Cristina Puche; Marta José; Albert Cabero; Anna Meseguer
Journal:  Eur J Endocrinol       Date:  2002-02       Impact factor: 6.664

3.  A direct role for C/EBP and the AP-I-binding site in gene expression linked to adipocyte differentiation.

Authors:  R Herrera; H S Ro; G S Robinson; K G Xanthopoulos; B M Spiegelman
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

4.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

Authors:  R S Legro; D Driscoll; J F Strauss; J Fox; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

5.  Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes.

Authors:  D Rosenbaum; R S Haber; A Dunaif
Journal:  Am J Physiol       Date:  1993-02

6.  Life without white fat: a transgenic mouse.

Authors:  J Moitra; M M Mason; M Olive; D Krylov; O Gavrilova; B Marcus-Samuels; L Feigenbaum; E Lee; T Aoyama; M Eckhaus; M L Reitman; C Vinson
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

7.  Molecular mechanism for repression of 17alpha-hydroxylase expression and androstenedione production in granulosa cells.

Authors:  Satin S Patel; Victor E Beshay; Julian C Escobar; Takashi Suzuki; Bruce R Carr
Journal:  J Clin Endocrinol Metab       Date:  2009-10-22       Impact factor: 5.958

8.  Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots.

Authors:  A Dicker; M Rydén; E Näslund; I E Muehlen; M Wirén; M Lafontan; P Arner
Journal:  Diabetologia       Date:  2004-01-30       Impact factor: 10.122

9.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients.

Authors:  Erik Jansen; Joop S E Laven; Henri B R Dommerholt; Jan Polman; Cindy van Rijt; Caroline van den Hurk; Jolanda Westland; Sietse Mosselman; Bart C J M Fauser
Journal:  Mol Endocrinol       Date:  2004-08-12
View more
  10 in total

Review 1.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

2.  A cell-autonomous molecular cascade initiated by AMP-activated protein kinase represses steroidogenesis.

Authors:  Houssein S Abdou; Francis Bergeron; Jacques J Tremblay
Journal:  Mol Cell Biol       Date:  2014-09-15       Impact factor: 4.272

3.  Involvement of Visceral Adipose Tissue in Immunological Modulation of Inflammatory Cascade in Preeclampsia.

Authors:  Katsuhiko Naruse; Juria Akasaka; Aiko Shigemitsu; Taihei Tsunemi; Natsuki Koike; Chiharu Yoshimoto; Hiroshi Kobayashi
Journal:  Mediators Inflamm       Date:  2015-05-31       Impact factor: 4.711

4.  Molecular mechanisms underlying altered neurobehavioural development of female offspring of mothers with polycystic ovary syndrome: FOS-mediated regulation of neurotrophins in placenta.

Authors:  Fangfang Wang; Ningning Xie; Jue Zhou; Minchen Dai; Qing Zhang; Paul J Hardiman; Fan Qu
Journal:  EBioMedicine       Date:  2020-09-16       Impact factor: 8.143

5.  Differences in expression of genes related to steroidgenesis in abdominal subcutaneous adipose tissue of pregnant women with and without PCOS; a case control study.

Authors:  Neda Emami; Ashraf Moini; Parichehreh Yaghmaei; Vahid Akbarinejad; Maryam Shahhoseini; AliReza Alizadeh
Journal:  BMC Pregnancy Childbirth       Date:  2021-07-07       Impact factor: 3.007

6.  Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome.

Authors:  Ning Xu; David H Geller; Michelle R Jones; Vincent A Funari; Ricardo Azziz; Mark O Goodarzi
Journal:  J Clin Transl Endocrinol       Date:  2015-09

7.  Differential proinflammatory and oxidative stress response and vulnerability to metabolic syndrome in habitual high-fat young male consumers putatively predisposed by their genetic background.

Authors:  Pedro González-Muniesa; María Pilar Marrades; José Alfredo Martínez; María Jesús Moreno-Aliaga
Journal:  Int J Mol Sci       Date:  2013-08-22       Impact factor: 5.923

8.  Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome.

Authors:  Milana Kokosar; Anna Benrick; Alexander Perfilyev; Romina Fornes; Emma Nilsson; Manuel Maliqueo; Carl Johan Behre; Antonina Sazonova; Claes Ohlsson; Charlotte Ling; Elisabet Stener-Victorin
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

9.  Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming.

Authors:  Karen L Leung; Smriti Sanchita; Catherine T Pham; Brett A Davis; Mariam Okhovat; Xiangming Ding; Phillip Dumesic; Tristan R Grogan; Kevin J Williams; Marco Morselli; Feiyang Ma; Lucia Carbone; Xinmin Li; Matteo Pellegrini; Daniel A Dumesic; Gregorio D Chazenbalk
Journal:  Clin Epigenetics       Date:  2020-11-23       Impact factor: 7.259

10.  Oxidized high-density lipoprotein enhances endocrine disorders and ovarian damage in rats.

Authors:  Lu Wang; Hongjuan Li; Xiaoke Tang; Yupei Yang; Yuancui Xiang; Hui Zhang; Yali Wang
Journal:  J Cell Mol Med       Date:  2021-08-04       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.